Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Kane Biotech Inc. V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company. The Company is engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. It has a portfolio of biotechnologies and products, which includes StrixNB, DispersinB, Aledex, bluestem, bluestem, silkstem, goldstem, coactiv+, coactiv+, DermaKB and DermaKB Biofilm. Its Wound Care & Surgical division is focused on the product development of DispersinB for applications in chronic wound care. Its bluestem product line includes water additives, chews, spray and dental wipes. Its other products in development stage include Coactiv+, antimicrobial wound rinse for use in acute and chronic wounds; Coactiv+, antimicrobial surgical hydrogel for use in surgical and acute wounds, and DispersinB Gel for prosthetic joint infection. It also provides Scalp Detoxifier, Shampoo and Shampoo Bars. Its primary markets for its technologies are animal health and human health.


TSXV:KNE - Post by User

Bullboard Posts
Post by CurlyMickon Sep 27, 2014 11:04am
149 Views
Post# 22976212

Fellow Longs and New Dreamers

Fellow Longs and New DreamersIMHO we are probably down to a patent sale as the last hope. The current management has done nothing but fail on its long stated objective of marketing its products. Gord was disappointed that it took longer than anticipated for the completion of the so-called DD. More importantly to me, he never articulated in any fashion any anticipated or target date for the DD completion and consequently obfuscated reality. It's easy not to take blame when so-called goals are undefined, nebulous or simply mamby-pamby. The management has driven down not only the share price of Kane Biotech, but any real chance of marketing its products because of its countless marketing blunders, poor communication skills, and transparent ineptitude. Just read the numerous upbeat announcements and ask yourself whatever came of those marketing programs? The list of failed marketing attempts is long.

Losing Dr. Sri points to the fact that Kane's management only wants to market the failures it has and not complete the original goals many of us long time dreamers envisioned....yes its MHO but I believe pretty much self-evident. While doggy breath and cat scratch fever are important, trying to boot-strap finance a company through the sale of previously rejected products seems irrational. 

Us longs knew that an infusion of cash would have to come. I have no problem with dilution, but I have a HUGE problem with dilution to support failed management and a failed strategy to create a value proposition that very few people see as having any value.

When the sell-off started a few of us speculated that the (allegedly Bayer) deal was dead...it seemed clear that some one knew that fact because of the way they were dumping shares. Now we know it's true and that we are back to square one...not innovating like a biotech co., but looking again for partners to sell our magic potions. Not our forte as history shows. 

I'm sorry if my harsh words shock the supportive wave of bottom feeding (a good strategy btw in the right circumstances) speculators that have shown up. Stay strapped in at your own peril IMHO.  

I have much less at stake now so happily for you I won't be posting as much as I used to about my once favourite junior innovator. 



Bullboard Posts